Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- industrial
- pharma
Iridium
CAS 1809322-71-1
Concern score
Not assessed — no hazard data yet.
Why it's flagged
EPA CPDat observed this chemical in 13 composition records across product categories including Laboratory supplies.
Regulation
No restrictions found. Iridium appears in these published regulatory listings.
- commercial_presence
- cpdat_category:industrial
- currently_marketed_ndc
- definition_level:complete
- definition_type:primary
- ingredient_type:ingredient substance
- marketed_drug_ingredient
- nsde_reference_present
USEPAcommercial use observedEPA CPDat observed this chemical in 13 composition records across product categories including Laboratory supplies.
- EPA CPDat observed this chemical in 13 composition records across product categories including Laboratory supplies.Source →
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 28 active drug products and 34 total products.
- FDA NDC lists this ingredient in 28 active drug products and 34 total products.Source →
USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
- openFDA substance registry classifies this ingredient as chemical.Source →
Evidence
No graded sources yet for Iridium. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Where it appears
Prevalence of Iridium in our catalog (fda_ndc).
Products
34
